Details of the Drug Formulaction

General Information of Drug Formulation (ID: F00616)

• Formulation Name: Alendronic acid 35 mg tablet
• Company: Rising Pharmaceuticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Alendronate	(DMY2KX9)	Bone Paget disease		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Magnesium stearate	(E00208)	11177	lubricant
Vinylpyrrolidone	(E00668)	Not Available	Binding agent; Coating agent; Disintegrant; Film/membrane-forming agent; Solubilizing agent; Suspending agent